Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.9400
+0.0396 (4.40%)
At close: May 12, 2026, 4:00 PM EDT
0.9800
+0.0400 (4.26%)
Pre-market: May 13, 2026, 4:14 AM EDT

Bio Green Med Solution Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2024FY 2024FY 2023
Period Ending
Dec '25 Mar '25 Dec '24 Mar '24 Dec '23
Net Income
-3-0.09-11.21-0.19-22.56
Depreciation & Amortization
0.0100.010.020.03
Stock-Based Compensation
2.33-0.59-1.47
Other Adjustments
4.950.27-0.17-
Change in Receivables
-1.260.06-0.14-
Changes in Inventories
-1.38-0.02-0.23-
Changes in Accrued Expenses
-10.51-0-1.81-0.050.3
Changes in Income Taxes Payable
--0.06-0-
Changes in Other Operating Activities
4.090.234.44-0.264.64
Operating Cash Flow
-4.770.39-7.990.06-16.11
Capital Expenditures
--0--0-0.01
Investing Cash Flow
--0--0-0.01
Long-Term Debt Issued
--0.07-0.02-
Net Long-Term Debt Issued (Repaid)
--0.07-0.02-
Issuance of Common Stock
6.43-7.82-1.05
Net Common Stock Issued (Repurchased)
6.43-7.82-1.05
Preferred Share Dividends Paid
-0.06----0.2
Other Financing Activities
-1.1----
Financing Cash Flow
5.26-0.077.820.020.85
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.130.02-0.07-0.010.3
Net Cash Flow
0.370.34-0.240.06-14.97
Free Cash Flow
-4.770.39-7.990.06-16.12
FCF Margin
-638.55%20.41%-9290.70%2.80%-1918.81%
Free Cash Flow Per Share
-2.180.13-358.072.66-4546.68
Levered Free Cash Flow
-21.89-0.02-8.58-0.2-17.79
Unlevered Free Cash Flow
-16.24-0.02-8.59-0.27-17.5
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.